Top Tweets for #FirstinClass

7 days ago

Psilera has closed an oversubscribed $8.8M raised #SeriesSeed funding round! #FirstInClass and #FirstInHuman data expected in 2027. Read the full details in the press release below: https://t.co/xtQNi7yu7n #MindfulMedicine #Psychedelics #Neuroplastogens

psilera's tweet photo. Psilera has closed an oversubscribed $8.8M raised #SeriesSeed funding round!

#FirstInClass and #FirstInHuman data expected in 2027.

Read the full details in the press release below: https://t.co/xtQNi7yu7n

#MindfulMedicine #Psychedelics #Neuroplastogens https://t.co/La6LFy3Ov7

24brussels.online @24brussels

20 days ago

Moscow narrows drug development subsidies as budget deficit tightens #Politics #Topstories #bestinclass #budgetdeficit #drugdevelopment #firstinclass #healthpolicy #pharmaceuticals #Russia #24brussels #breaking #news #europe #brussels #belgium https://t.co/CuuwMeJELH

HAYA Therapeutics @HAYA_lncRNA

27 days ago

#HAYA is heading to the #RIS2026! Connect with our #CBO, @drrichjlaw to learn about our #Pulmonary programs focused on advancing #FirstInClass solutions for the #Treatment of #IPF by leveraging #noncodingRNAs.🫁🧬 If you attending, let’s connect!🤝

HAYA_lncRNA's tweet photo. #HAYA is heading to the #RIS2026!

Connect with our #CBO, @drrichjlaw to learn about our #Pulmonary programs focused on advancing #FirstInClass solutions for the #Treatment of #IPF by leveraging #noncodingRNAs.🫁🧬

If you attending, let’s connect!🤝 https://t.co/Bl7ngZ6DyY

829

MedChemExpress

@MedChemExpress

about 2 months ago

Advancing cancer research together with MedChemExpress. Several drugs are being unveiled for the first time at the AACR 2026 Annual Meeting. Stop by Booth #1742 to explore how we can support your research. https://t.co/rYdPnzkSQ5 #AACR #AACR2026 #drugdiscovery #firstinclass

MedChemExpress

@MedChemExpress

about 2 months ago

🧬AACR 2026 New Molecule Readouts AACR is ongoing. Here’s a look at the New Drugs emerging across #TPD, #ADCs, #bispecifics, and immune modulation. 01 | NEO-811 A molecular glue degrader targeting ARNT (HIF-1β), with strong single-agent activity in clear cell renal cell carcinoma (ccRCC). 02 | #AZD8359 A CD8-biased T cell engager designed to expand the therapeutic window in prostate cancer. 03 | #TNG961 A selective oral HBS1L molecular glue degrader for FOCAD-deficient cancers. 04 | #EPI-326 A mutation-agnostic EGFR bispecific that promotes EGFR degradation while sparing normal tissues in EGFR-driven solid tumors. 05 | E-688 (#HLX316) A first-in-class B7-H3-targeted sialidase designed to enhance innate and adaptive anti-tumor immunity. 06 | #ECI830 A potent and selective CDK2 inhibitor targeting HR+/HER2- breast cancer and CCNE1-amplified tumors. 07 | TRI-611 A CNS-penetrant ALK molecular glue degrader for ALK fusion-positive non-small cell lung cancer. 08 | CD30 ADC program A dual-payload ADC combining MTI + Topo1 inhibitors to overcome resistance mechanisms. 09 | CID-078 A first-in-class oral macrocyclic cyclin A/B–RxL inhibitor targeting RB1-deficient or E2F-driven cancers. 10 | AMX-883 An orally bioavailable BRD9 degrader acting as a differentiation therapy for acute myeloid leukemia (AML). 11 | ENPP3 ADC (JNJ-89862175) A novel ENPP3-targeted ADC undergoing preclinical characterization in advanced solid tumors. 12 | #IPN01203 A dual T cell agonist designed to activate VB6/VB10 TCR-expressing T cells. https://t.co/utu1uGDIUe MedChemExpress welcomes you to Booth #1742 to connect and exchange ideas—and pick up exclusive lab merch and woven totes! #NEO811 #E688 #TRI611 #CID078 #AMX883 #JNJ89862175 #TargetedProteinDegradation #MolecularGlue #Oncology #DrugDiscovery

MedChemExpress's tweet photo. 🧬AACR 2026 New Molecule Readouts
AACR is ongoing. Here’s a look at the New Drugs emerging across #TPD, #ADCs, #bispecifics, and immune modulation.

01 | NEO-811
A molecular glue degrader targeting ARNT (HIF-1β), with strong single-agent activity in clear cell renal cell carcinoma (ccRCC).

02 | #AZD8359
A CD8-biased T cell engager designed to expand the therapeutic window in prostate cancer.

03 | #TNG961
A selective oral HBS1L molecular glue degrader for FOCAD-deficient cancers.

04 | #EPI-326
A mutation-agnostic EGFR bispecific that promotes EGFR degradation while sparing normal tissues in EGFR-driven solid tumors.

05 | E-688 (#HLX316)
A first-in-class B7-H3-targeted sialidase designed to enhance innate and adaptive anti-tumor immunity.

06 | #ECI830
A potent and selective CDK2 inhibitor targeting HR+/HER2- breast cancer and CCNE1-amplified tumors.

07 | TRI-611
A CNS-penetrant ALK molecular glue degrader for ALK fusion-positive non-small cell lung cancer.

08 | CD30 ADC program
A dual-payload ADC combining MTI + Topo1 inhibitors to overcome resistance mechanisms.

09 | CID-078
A first-in-class oral macrocyclic cyclin A/B–RxL inhibitor targeting RB1-deficient or E2F-driven cancers.

10 | AMX-883
An orally bioavailable BRD9 degrader acting as a differentiation therapy for acute myeloid leukemia (AML).

11 | ENPP3 ADC (JNJ-89862175)
A novel ENPP3-targeted ADC undergoing preclinical characterization in advanced solid tumors.

12 | #IPN01203
A dual T cell agonist designed to activate VB6/VB10 TCR-expressing T cells.
https://t.co/utu1uGDIUe

MedChemExpress welcomes you to Booth #1742 to connect and exchange ideas—and pick up exclusive lab merch and woven totes!

#NEO811 #E688 #TRI611 #CID078 #AMX883 #JNJ89862175 #TargetedProteinDegradation #MolecularGlue #Oncology #DrugDiscovery

649

309

Ashuttosh Kumar Jha @iashutoshmohit

2 months ago

First-in-Class defines a new mechanism. Best-in-Class refines it to outperform. In oncology, success often lies in who executes better, not just who gets there first. #Oncology #DrugDevelopment #FirstInClass #BestInClass #Pharma

iashutoshmohit's tweet photo. First-in-Class defines a new mechanism. Best-in-Class refines it to outperform. In oncology, success often lies in who executes better, not just who gets there first.
#Oncology #DrugDevelopment #FirstInClass #BestInClass #Pharma https://t.co/DU1Cl05ICT

Jimmy’s Stew🇨🇦- Gone Until September @jimmysstew

3 months ago

@SensCentral Thanks pal! #firstinclass lol

Poonam Meena

@ItsPoonamMeena

4 months ago

Grateful for this honour. Proud that Team RSKV No.2, Jama Masjid proves a government school stands tall in academic excellence. Thank you Hon’ble Minister Sh. Ashish Sood ji and the entire team for the encouragement. We remain committed to every child’s success. #FirstInClass

NewsX World

@NewsX

4 months ago

NewsX is thrilled to congratulate RSKV NO.2, Jama Masjid for winning the prestigious First In Class 2026 Award in the 'Best in Academics' category from Hon'ble Minister of Education of Delhi, Ashish Sood ( @ashishsood_bjp). The ceremony at the First In Class Conclave was held in the presence of Dr. Aishwarya Pandit Sharma (@DrAishwarya_PT). #FirstInClass #ExcellenceInEducation

NewsX's tweet photo. NewsX is thrilled to congratulate RSKV NO.2, Jama Masjid for winning the prestigious First In Class 2026 Award in the 'Best in Academics' category from Hon'ble Minister of Education of Delhi, Ashish Sood (
@ashishsood_bjp). The ceremony at the First In Class Conclave was held in the presence of Dr. Aishwarya Pandit Sharma (@DrAishwarya_PT).
#FirstInClass #ExcellenceInEducation

642

386

Priya Sahgal @Priyascorner

4 months ago

https://t.co/tpyP7CO8Me @jayantrld congratulates @NewsX on our education conclave #FirstinClass

173

Priya Sahgal @Priyascorner

4 months ago

https://t.co/KRJcyDCIUa - Live Link to watch our Education Conclave #FirstinClass where we talk to Principals, teachers, parents students and ministers abt NEP, Social Media and new age education, career counselling, smart classrooms, peer pressure.. @NewsX @NetworkItv

122

Coeurative, Inc @CoeurativeInc

4 months ago

Annual mortality rates for refractory angina patients reach up to 17%. Current standard-of-care options fail to address this devastating risk, creating an urgent imperative for first-in-class therapies. #RefractoryAngina #CardiovascularDisease #UnmetMedicalNeed #FirstInClass

$CoeurativeInc's tweet photo. Annual mortality rates for refractory angina patients reach up to 17%. Current standard-of-care options fail to address this devastating risk, creating an urgent imperative for first-in-class therapies. #RefractoryAngina #CardiovascularDisease #UnmetMedicalNeed #FirstInClass https://t.co/RB0ehUNHL5$

Remoulade Randy @corndogwaffle

6 months ago

@KnoxKiffinQB All good brother. You got two more years to win it all at #FirstInClass #TheOxfordWay !

Remoulade Randy @corndogwaffle

7 months ago

@Masolifanpage8 #FirstInClass, #TheOxfordWay

Niclas Holmgren (Oncozengemannen)

@PeritusRecta

7 months ago

Glöm inte att följa! Spännande veckor framöver. https://t.co/XAHJRFL2Pw $Oncoz #Oncozenge #Oralpain #firstinclass #painrelief

Shawn_Anderson @Shawn_Anderson

8 months ago

#FirstInClass eh, #Sens … this is awful to watch.

Durable Drive

@fortunoaurelar

10 months ago

Amtagvi is the first FDA‑approved T‑cell therapy for ANY solid tumor. A paradigm shift that started with melanoma—next stop: lung & beyond. #FirstInClass #Innovation $IOVA

948

AccidentalExpression @BlogToWorld

12 months ago

Our time has come! 😇🙏🙏🙏 @Ocugen #FirstInClass #GeneTherapy #CourageousInnovation

242

k!NG Tafari🇬🇭🇷🇼🇳🇬 @nanA_AntWi_

about 1 year ago

It’s a cole world ,We All born sinners #FirstInClass #OmarSterling

@CDTI_innovacion

about 1 year ago

🚀Promovemos la #innovación apoyando con #AyudasCDTI proyectos como el de #VivaInVitro 👇 🧬Detección de #inmunosupresión y #estratificación de #sepsis automatizada IVD mediante dispositivo #FirstInClass basado en #NLRP3 👉 https://t.co/vAW3K7oq9n 🎞️Apoyando a través de ayudas #NEOTEC: https://t.co/6uDsFJW7cY #FondosEuropeos #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #AyudandoCrearFuturo #Agenda2030 #ODS3

CDTI_innovacion's tweet photo. 🚀Promovemos la #innovación apoyando con #AyudasCDTI proyectos como el de #VivaInVitro 👇

🧬Detección de #inmunosupresión y #estratificación de #sepsis automatizada IVD mediante dispositivo #FirstInClass basado en #NLRP3 👉 https://t.co/vAW3K7oq9n

🎞️Apoyando a través de ayudas #NEOTEC: https://t.co/6uDsFJW7cY

#FondosEuropeos #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #AyudandoCrearFuturo #Agenda2030 #ODS3

383

Channel 44 TV @Channel44LIVE

about 1 year ago

Ashley is now first in her class—by God’s grace! She’s here to testify of His goodness and favor. #GodDidIt #Testimony #FirstInClass #DivineFavor

Channel44LIVE's tweet photo. Ashley is now first in her class—by God’s grace! She’s here to testify of His goodness and favor.
#GodDidIt #Testimony #FirstInClass #DivineFavor https://t.co/HIP3EffYgr

423

Talk of the Town PR @TalkoftheTownPR

about 1 year ago

@ARITZIA #firstinclass #boutiqueexperience our associate knew our names, stayed attentive, the quality of the clothing….you can’t even get this kind of dedication at @Nordstrom or @saks and the price is reasonable. Another successful #retail experience #Gratitude

Top Tweets for #FirstinClass

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users